Overview

The Canadian Institutes of Health Research (CIHR), in collaboration with the Multiple Sclerosis (MS) Society of Canada, convened a meeting of top researchers in Ottawa on August 26, 2010, to identify priorities for Canada that would accelerate research and innovation on treatments for MS. The meeting focused, in particular, on links between neurovascular issues and MS.

There was a wide range of internationally recognized participants with expertise in neurology, vascular surgery, neurosurgery, neuro- and vascular imaging, neuropathology, neuro- and cardioimmunology, basic science, and epidemiology. Participants also included federal and provincial government representatives and a person living with MS. …continue reading »